95.23 - 97.14
55.47 - 103.81
1.63M / 1.80M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-25.55%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-29.83%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-19.91%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-19.91%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-18.31%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-10.00%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-11.11%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
4.01%
Share change of 4.01% while NEM is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
-0.11%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
No Data
No Data available this quarter, please select a different quarter.
-41.69%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-41.69%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
115.32%
10Y revenue/share CAGR above 1.5x NEM's 51.16%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
59.36%
5Y revenue/share CAGR 1.25-1.5x NEM's 39.59%. Bruce Berkowitz would verify if cost efficiency or pricing power supports this advantage.
46.89%
3Y revenue/share CAGR above 1.5x NEM's 17.48%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
No Data
No Data available this quarter, please select a different quarter.
580.66%
Positive OCF/share growth while NEM is negative. John Neff might see a comparative advantage in operational cash viability.
89.09%
Positive 3Y OCF/share CAGR while NEM is negative. John Neff might see a big short-term edge in operational efficiency.
No Data
No Data available this quarter, please select a different quarter.
506.67%
5Y net income/share CAGR above 1.5x NEM's 50.14%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
114.08%
3Y net income/share CAGR above 1.5x NEM's 48.92%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
934.37%
10Y equity/share CAGR above 1.5x NEM's 86.87%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
1372.10%
5Y equity/share CAGR above 1.5x NEM's 21.79%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
249.39%
Positive short-term equity growth while NEM is negative. John Neff sees a strong advantage in near-term net worth buildup.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-83.67%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
No Data
No Data available this quarter, please select a different quarter.
-8.63%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
0.58%
Positive BV/share change while NEM is negative. John Neff sees a clear edge over a competitor losing equity.
-27.61%
We’re deleveraging while NEM stands at 4.51%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
-40.67%
We cut SG&A while NEM invests at 27.03%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.